Exploring the antineoplastic effect of phytochemicals from Ipomea sepiaria against matrix metallopeptidases: a pharmacoinformatics approach Online publication date: Tue, 30-Jun-2020
by S.S. Ariya; Baby Joseph; Jemmy Christy
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 13, No. 3, 2020
Abstract: Cancer is one of the leading causes of death worldwide. Though advanced treatment options are available, a cure for this disease is still unidentified. This work is aimed at the identification of drugs to target the matrix metallopeptidase, a major protein overexpressed in this disease. Two hundred and forty seven active phytochemicals from the medicinal plant Ipomea sepiaria were taken as the lead drugs and molecular docking analysis as well as interaction studies were carried out. The binding affinity for each ligand with the target was determined along with Molecular dynamic simulation of the complex to determine the stability of the complex in the system. Thus eight drugs namely Tetradecanoic acid, Nerolidol, Ipomeanine, Dibutyl phthalate, Cis-Caffeic acid, Caffeic acid, Moupinamide and N-Cis-Feruloyltyramine were found to be the most promising drugs for treating cancer. They outperformed the scores of four different drugs available in the market.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook